Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Zallio

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|September 12, 2002
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphomaF Zallio, A Cuttica, D Caracciolo, et al.
Bone Marrow Transplantation|November 20, 2002
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilizationC Tarella, M Di Nicola, D Caracciolo, et al.
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Haematologica|September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for LymphomasC Guglielmi, M Martelli, M Federico, et al.
Leukemia Research|April 9, 2011
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-CM T Corsetti, F Salvi, S Perticone, et al.
Bone Marrow Transplantation|June 6, 2017
Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphomaL Giaccone, M Festuccia, F Zallio, et al.
Annals of Hematology|January 5, 2002
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developmentsC Tarella, A Cuttica, D Caracciolo, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Annals of Hematology|September 12, 2002
Feasibility of peripheral blood progenitor cell mobilization and harvest to support chemotherapy intensification in elderly patients with poor prognosis: non-Hodgkin's lymphomaF Zallio, A Cuttica, D Caracciolo, et al.
Bone Marrow Transplantation|November 20, 2002
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilizationC Tarella, M Di Nicola, D Caracciolo, et al.
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Haematologica|September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for LymphomasC Guglielmi, M Martelli, M Federico, et al.
Leukemia Research|April 9, 2011
Hematologic improvement and response in elderly AML/RAEB patients treated with valproic acid and low-dose Ara-CM T Corsetti, F Salvi, S Perticone, et al.
Bone Marrow Transplantation|June 6, 2017
Long-term follow-up of allogeneic stem cell transplantation in relapsed/refractory Hodgkin lymphomaL Giaccone, M Festuccia, F Zallio, et al.
Annals of Hematology|January 5, 2002
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developmentsC Tarella, A Cuttica, D Caracciolo, et al.
Leukemia|December 26, 2001
Concurrent administration of high-dose chemotherapy and rituximab is a feasible and effective chemo/immunotherapy for patients with high-risk non-Hodgkin's lymphomaM Ladetto, F Zallio, S Vallet, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2005
Effect of age and previous autologous transplantation on nonrelapse mortality and survival in patients treated with reduced-intensity conditioning and allografting for advanced hematologic malignanciesP Corradini, F Zallio, J Mariotti, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 13, 2020
Refractory and 17p-deleted chronic lymphocytic leukemia: improving survival with pathway inhibitors and allogeneic stem cell transplantationL Farina, F Barretta, L Scarfò, et al.
Pageof 3